The Chemours Company (CC)
NYSE: CC · Real-Time Price · USD
12.70
+0.16 (1.28%)
At close: Dec 5, 2025, 4:00 PM EST
13.00
+0.30 (2.36%)
After-hours: Dec 5, 2025, 7:00 PM EST
The Chemours Company Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for The Chemours Company stock have an average target of 17, with a low estimate of 13 and a high estimate of 27. The average target predicts an increase of 33.86% from the current stock price of 12.70.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for The Chemours Company stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 4 | 4 | 3 | 3 | 3 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 8 | 8 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold Maintains $15 → $13 | Hold | Maintains | $15 → $13 | +2.36% | Dec 3, 2025 |
| UBS | UBS | Strong Buy Maintains $21 → $18 | Strong Buy | Maintains | $21 → $18 | +41.73% | Nov 11, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $21 → $18 | Strong Buy | Maintains | $21 → $18 | +41.73% | Nov 10, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $19 → $17 | Buy | Maintains | $19 → $17 | +33.86% | Nov 10, 2025 |
| Mizuho | Mizuho | Buy Maintains $19 → $18 | Buy | Maintains | $19 → $18 | +41.73% | Oct 16, 2025 |
Financial Forecast
Revenue This Year
5.98B
from 5.78B
Increased by 3.34%
Revenue Next Year
6.23B
from 5.98B
Increased by 4.20%
EPS This Year
1.01
from 0.57
Increased by 77.07%
EPS Next Year
1.85
from 1.01
Increased by 83.39%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 6.2B | 6.5B | |
| Avg | 6.0B | 6.2B | |
| Low | 5.7B | 5.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 6.5% | 8.4% | |
| Avg | 3.3% | 4.2% | |
| Low | -2.1% | -2.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.47 | 2.25 | |
| Avg | 1.01 | 1.85 | |
| Low | 0.77 | 1.43 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 157.9% | 123.3% | |
| Avg | 77.1% | 83.4% | |
| Low | 35.8% | 41.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.